Search
Sino Medical Secures Conditional FDA Approval for Innovative Drug-Eluting Stent System
2025-07-21 /
Read about 0 minute
Author：小编
Sino Medical has announced the conditional approval of its groundbreaking drug-eluting stent system by the U.S. Food and Drug Administration (FDA). This system, rooted in the company's pioneering concept of the "arterial wound healing time window," is designed to expedite patient recovery and minimize adverse events. This milestone marks the first time a domestically originated medical device from China has obtained pre-market approval in the United States. The system boasts global patents and has undergone clinical trials in several countries. Nevertheless, Sino Medical must fulfill the additional requirements outlined by the FDA before achieving full approval and commercialization.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
